About us

Orange Biotech, established in 2022 in Hong Kong, is a reagent company specializing in our exclusive CRISPR technology and microfluidics. Our team comprises experts from esteemed institutions such as the Hong Kong University of Science and Technology (HKUST) and the University of Oxford. Our mission is to become a comprehensive Point of Care Testing (POCT) company, providing accessible and affordable diagnostic solutions for home-based nucleic acid tests not limited to disease confirmation, but also in disease prevention and re-examination after drug treatment.